March 18, 2018 7:49 PM ET


Company Overview of C4 Therapeutics, Inc.

Company Overview

C4 Therapeutics, Inc. develops targeted protein degradation therapeutics for the treatment of various diseases. It develops Degronimid platform that incorporates small molecule binders to target disease-causing proteins and facilitate their destruction and clearance from the cell through the natural ubiquitin/proteasome system. C4 Therapeutics, Inc. has strategic collaborations with Roche Pharma and Calico Life Sciences LLC. The company was incorporated in 2015 and is based in Cambridge, Massachusetts.

675 West Kendall Street

Cambridge, MA 02142

United States

Founded in 2015



Key Executives for C4 Therapeutics, Inc.

President and Chief Scientific Officer
Co-Founder and Executive Chairman
Age: 54
Age: 45
Co-Founder and Member of Scientific Advisory Board
Age: 66
Co-Founder and Member of Scientific Advisory Board
Compensation as of Fiscal Year 2017.

C4 Therapeutics, Inc. Key Developments

C4 Therapeutics Appoints Ron Kaiser as Chief Financial Officer

C4 Therapeutics announced it has appointed Ron Kaiser as Chief Financial Officer. Ron has more than three decades of extensive executive management and financial leadership experience in financial reporting, funding and growth management. He also served on C4T’s Board of Directors from January 2016 until October 2017. Over a span of 35 years, Ron has led six companies through IPO funding in multiple roles, including Chief Financial Officer and Treasurer, and helped manage dozens of major business transactions. He has served as a board member for several public and private entities.

C4 Therapeutics Appoints Michael Kim as Vice President of Business Development

C4 Therapeutics announced the appointment of Michael Kim as Vice President of Business Development. Dr. Kim comes to C4 Therapeutics from ARIAD Pharmaceuticals where he held responsibilities for partnering activities around early and late stage programs in addition to portfolio strategy and alliance management. He started his business career as a strategy consultant with Leerink Swann and company and progressed to Corporate Strategy and Business Development roles of increasing responsibility at Alkermes, Vertex Pharmaceuticals and FORUM Pharmaceuticals.

C4 Therapeutics Announces Appointments to its Scientific Advisory Board

C4 Therapeutics announced the appointment of Scott Armstrong and Ross Levine to the company's Scientific Advisory Board. Scott Armstrong is the Chairman of the Department of Pediatric Oncology and the Director of the Center for Pediatric Cancer Therapeutics at the Dana-Farber Cancer Institute. He is also the David G. Nathan Professor of Pediatrics at Harvard Medical School and Associate Chief of the Division of Hematology/Oncology at Boston Children’s Hospital. His laboratory program studies the role of histone modifications and chromosome structure as a critical initial step in leukemia development. Ross Levine is an attending physician and the Laurence Joseph Dineen Chair in Leukemia Research at Memorial Sloan-Kettering Cancer Center in the Human Oncology and Pathogenesis Program and Leukemia Service. Additionally, he is a Professor of Medicine at Weill Cornell Medical College and is the Director of the MSK Center for Hematologic Malignancies. His laboratory program is focused on the molecular basis of myeloid malignancies, with a specific focus on signaling and epigenetics and mechanism based therapeutics.

Similar Private Companies By Industry

Company Name Region
20n Labs, Inc. United States
23andMe, Inc. United States
2C Tech Corporation, Inc. United States
3-V Biosciences, Inc. United States
3Bar Biologics Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
Tax Management Inc United States
John F. Kennedy Center For The Performing Arts United States
NYC2012, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact C4 Therapeutics, Inc., please visit Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at